These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24678707)

  • 1. Recent advances in delivery through the blood-brain barrier.
    Larsen JM; Martin DR; Byrne ME
    Curr Top Med Chem; 2014; 14(9):1148-60. PubMed ID: 24678707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
    Song J; Lu C; Leszek J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues.
    Chen YC; Chiang CF; Chen LF; Liao SC; Hsieh WY; Lin WL
    Biomaterials; 2014 Feb; 35(6):2051-65. PubMed ID: 24315575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
    Varghese NM; Senthil V; Saxena SK
    J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood-brain barrier and brain drug delivery.
    Koziara JM; Lockman PR; Allen DD; Mumper RJ
    J Nanosci Nanotechnol; 2006; 6(9-10):2712-35. PubMed ID: 17048477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
    Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
    FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.
    Li J; Zheng M; Shimoni O; Banks WA; Bush AI; Gamble JR; Shi B
    Adv Sci (Weinh); 2021 Aug; 8(16):e2101090. PubMed ID: 34085418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
    Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X
    Small; 2017 Nov; 13(43):. PubMed ID: 29045030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.